|
PAS-004 Capsule Clinical Trials
1 actively recruiting trial across 1 location
Pipeline
Phase 1: 1
Top Sponsors
- Pasithea Therapeutics Corp.1
Indications
- Neurofibromatosis Type 1 (NF1)1
- Neurofibromatosis Type 1 (NF1)-Related Plexiform Neurofibromas (PNs)1
- Neurofibroma, Plexiform1
- NF1 Mutation1
- Cancer1
Birmingham, Alabama1 trial
PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
University of Alabama at Birmingham
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.